Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Radiol ; 22(5): 1114-21, 2012 May.
Article in English | MEDLINE | ID: mdl-22138735

ABSTRACT

OBJECTIVES: To evaluate the effectiveness of the iterative decomposition of water and fat with echo asymmetric and least-squares estimation (IDEAL) MRI to quantify tumour infiltration into the lumbar vertebrae in myeloma patients without visible focal lesions. METHODS: The lumbar spine was examined with 3 T MRI in 24 patients with multiple myeloma and in 26 controls. The fat-signal fraction was calculated as the mean value from three vertebral bodies. A post hoc test was used to compare the fat-signal fraction in controls and patients with monoclonal gammopathy of undetermined significance (MGUS), asymptomatic myeloma or symptomatic myeloma. Differences were considered significant at P < 0.05. The fat-signal fraction and ß(2)-microglobulin-to-albumin ratio were entered into the discriminant analysis. RESULTS: Fat-signal fractions were significantly lower in patients with symptomatic myelomas (43.9 ±19.7%, P < 0.01) than in the other three groups. Discriminant analysis showed that 22 of the 24 patients (92%) were correctly classified into symptomatic or non-symptomatic myeloma groups. CONCLUSIONS: Fat quantification using the IDEAL sequence in MRI was significantly different when comparing patients with symptomatic myeloma and those with asymptomatic myeloma. The fat-signal fraction and ß(2)-microglobulin-to-albumin ratio facilitated discrimination of symptomatic myeloma from non-symptomatic myeloma in patients without focal bone lesions. KEY POINTS: • A new magnetic resonance technique (IDEAL) offers new insights in multiple myeloma. • Fat-signal fractions were lower in patients with symptomatic myelomas than in those with asymptomatic myelomas. • The ß2-microglobulin-to-albumin ratio also aided discrimination of symptomatic myeloma. • The fat-signal fraction may provide information about the myeloma cell mass.


Subject(s)
Adipose Tissue/pathology , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Multiple Myeloma/pathology , Spine/pathology , Subtraction Technique , Water/analysis , Aged , Algorithms , Female , Humans , Image Enhancement/methods , Least-Squares Analysis , Lumbar Vertebrae/pathology , Male , Middle Aged , Pilot Projects , Reproducibility of Results , Sensitivity and Specificity
2.
Magn Reson Med Sci ; 8(4): 143-8, 2009.
Article in English | MEDLINE | ID: mdl-20035122

ABSTRACT

PURPOSE: Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) is a recently developed liver-specific contrast agent for magnetic resonance (MR) imaging that is excreted equally via the kidneys and the biliary system. To our knowledge, its effects on T(2)-weighted MR cholangiopancreatography (MRCP) images have not been explored. Acquisition of the hepatobiliary phase is recommended 20 min after administration of Gd-EOB-DTPA. Examination time cannot be extended if the contrast does not take effect on T(2)-weighted MRCP within 20 min after administration. We attempted to assess the change in signal of T(2)-weighted MRCP by excretion of Gd-EOB-DTPA. METHODS: Between March and July 2008, 40 patients (15 women, 25 men; mean age 70.8 years) were examined with abdominal MR imaging. T(2)-weighted MRCP was performed before and 10 and 20 min after administration of Gd-EOB-DTPA. We analyzed signal intensity of the bile duct, gallbladder, cystic duct, and pancreatic duct on MRCP for changes in intensity. RESULTS: T(2)-weighted MRCP 20 min after contrast administration showed loss of signal of the bile duct (intrahepatic bile duct in all cases, upper extrahepatic duct in 36 [90%], middle extrahepatic duct in 33 [85%], and lower extrahepatic duct in 26 [67%]), the gallbladder in 23 cases (72%), and the cystic duct in 25 (64%). This signal change increased with time. We observed no change in signal of the pancreatic duct. CONCLUSION: T(2)-weighted MRCP sequences should not be obtained after administration of Gd-EOB-DTPA because this contrast agent decreases signal intensity of the biliary structure on these images.


Subject(s)
Cholangiopancreatography, Magnetic Resonance/methods , Contrast Media , Gadolinium DTPA , Aged , Aged, 80 and over , Bile Ducts/metabolism , Bile Ducts/pathology , Contrast Media/pharmacokinetics , Cystic Duct/metabolism , Cystic Duct/pathology , Female , Gadolinium DTPA/pharmacokinetics , Gallbladder/metabolism , Gallbladder/pathology , Humans , Male , Middle Aged , Pancreatic Ducts/metabolism , Pancreatic Ducts/pathology , Time Factors
3.
Magn Reson Med Sci ; 1(1): 50-3, 2002.
Article in English | MEDLINE | ID: mdl-16037668

ABSTRACT

We report a case of MELAS in which lesions were detected by perfusion-weighted MR imaging. Perfusion-weighted MRI using contrast media (PWI) and FAIR (flow-sensitive alternating inversion recovery), an arterial spin labeling method, clearly showed these lesions as hyperperfused areas. One of these lesions, diminished after steroid therapy, could also be detected by FAIR.


Subject(s)
MELAS Syndrome/diagnosis , Magnetic Resonance Imaging/methods , Adolescent , Diagnosis, Differential , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...